Number of the records: 1  

Neoplasma

  1. TitleNeoplasma
    Subtitlejournal of experimental and clinical oncology
    Author infoCancer Research Institute of the Slovak Academy of Sciences
    ISSN0028-2685
    Year, No.Vol. 69 no. 6 (2022)
    Issue dataBratislava : AEPress . - s. 1253-1498
    ReferencesPERIODIKÁ-Súborný záznam periodika (0.0-)
    ARTICLES2022:
    Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma Internal Prognostic Index (0.0-),
    Cancer-associated fibroblasts subtypes and role in invasion and metastasis of gastric cancer (0.0-),
    Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection (0.0-),
    Correlation between gastritis cystica profunda and the risk of lymph node metastasis in early gastric cancer (0.0-),
    Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer (0.0-),
    Evaluation of serum glucose-regulated protein 78 as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study (0.0-),
    Functions of long non-coding RNA LNC11649 in non-small cell lung cancer cells as a reprocessed form of MALAT1 (0.0-),
    GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling (0.0-),
    HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21 (0.0-),
    LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway (0.0-),
    Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer (0.0-),
    miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/β-catenin signaling pathway (0.0-),
    Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules (0.0-),
    Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carinoma (0.0-),
    Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression (0.0-),
    PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis (0.0-),
    PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance (0.0-),
    Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data (0.0-),
    Safety and efficacy of the FLOT regimen in the Polish population-an analysis of the prospective trial (0.0-),
    Stanniocalcin1 knockdown induces ferroptosis and suppresses gycolysis in prostate cancer via the Nrf2 pathway (0.0-),
    SUMO1-modified DNA methyltransferase 1 induces DNA hypermethylation of VWC2 in the development of colorectal cancer (0.0-),
    The prognostic impact of immune checkpoint inhibitors for treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study (0.0-),
    The role of SPDEF in cancer: promoter or suppressor (0.0-),
    TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation (0.0-)
    Periodicals statusAccepted (02.02.2023)
    LanguageEnglish
    CountrySlovak Republic
    Copy count1, currently available 0, at library only 1
    Document kindČasopisy
    DatabasePERIODIKÁ - Prijaté čísla
    journal

    journal

                               
    SignatúraLokáciaDislokáciaInfo
    C 720
    študovňa - časopisy: bežný rok a 3 roky spätne
    len prezenčne
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.